EUVIMEDEUVIMED entdecken
Crossref

Human immunodeficiency virus treatment adherence and outcomes in pregnant women among key populations in Nigeria

Olaniyi Felix Sanni, Paul Umoh, Roger Abang, Paul Amechi, Ochonye Boniface Bartholomew, Kelvin Emenike, Abiye Kalaiwo

Journal of Reproductive Healthcare and Medicine · 18.07.2026 · 7 · 10

DOI: 10.25259/jrhm_40_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reproductive Healthcare and Medicine, online erschienen am 18.07.2026. Verfasst von Olaniyi Felix Sanni und 6 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Over the past two decades, numerous global health programs and interventions have been implemented to prevent mother-to-child transmission of human immunodeficiency virus (HIV). This study aims to examine the association between antiretroviral therapy (ART) adherence-related factors and viral load suppression among pregnant women in key populations (KPs). Materials and Methods: This study used a retrospective quantitative research design to assess the association between ART adherence-related factors and viral load suppression among pregnant female sex workers (FSW) and people who inject drugs (PWID). The participants are enrolled in HIV treatment programs at Heartland Alliance Limited by Guarantee (LTD/GTE) One Stop Shops across eight selected states in Nigeria. Descriptive statistics and the chi-square test were used to summarize the demographic and clinical characteristics of the study participants.

Results

The socio-demographic of the study shows that among the participants ( n = 59), 88.1% were FSW, and 11.9% were PWID. The majority resided in Akwa Ibom (47.5%) and Cross River (45.8%), with most aged 26–33 years (42.4%). Nearly all (93.2%) received community-based treatment, and 100% were on first-line ART regimens. Most participants had ARV refill intervals of 5–6 months (88.1%) and treatment durations of 1–5 years (79.7%). The study found that 96.6% of participants achieved viral load suppression, with suppression rates significantly associated with treatment adherence (χ 2 = 59.000, p < 0.001), refill intervals (χ 2 = 29.052, p < 0.001), and state of residence (χ 2 = 29.596, p < 0.001).

Conclusion

The findings reveal that high adherence rates are strongly associated with viral suppression, which is essential for reducing the risk of mother-to-child HIV transmission and improving overall maternal health.

Zitieren

APA

Sanni, O. F., Umoh, P., Abang, R., Amechi, P., Bartholomew, O. B., Emenike, K., & Kalaiwo, A. (2026). Human immunodeficiency virus treatment adherence and outcomes in pregnant women among key populations in Nigeria. Journal of Reproductive Healthcare and Medicine, 7, 10. https://doi.org/10.25259/jrhm_40_2025

Vancouver

Sanni OF, Umoh P, Abang R, Amechi P, Bartholomew OB, Emenike K, et al. Human immunodeficiency virus treatment adherence and outcomes in pregnant women among key populations in Nigeria. Journal of Reproductive Healthcare and Medicine. 2026;7:10. doi:10.25259/jrhm_40_2025

BibTeX
@article{Sanni2026,
  author = {Sanni, Olaniyi Felix and Umoh, Paul and Abang, Roger and Amechi, Paul and Bartholomew, Ochonye Boniface and Emenike, Kelvin and Kalaiwo, Abiye},
  title = {Human immunodeficiency virus treatment adherence and outcomes in pregnant women among key populations in Nigeria},
  journal = {Journal of Reproductive Healthcare and Medicine},
  year = {2026},
  volume = {7},
  pages = {10},
  doi = {10.25259/jrhm_40_2025}
}
Kostenlos starten →